Advancing Inflammatory Disease Treatment: Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program

Tuesday, September 30, 2025

10:00 AM – 11:00 AM ET

Moderator

Jason Kolbert

Head of Research
D. Boral Capital

Panelists

Dr. Roger Pomerantz, M.D.

Vice Chairman,

Enlivex Therapeutics

Professor Philip Conaghan

Prof of Musculoskeletal Medicine,
University of Leeds
& Director, NIHR Leeds Biomedical Research Centre

Professor Ali Mobasheri

Musculoskeletal Biology,
Research Unit of Health Sciences and Technology,
Faculty of Medicine,
University of Oulu, Finland

Watch Webinar